Midterm Clinical Outcomes for Deferred Coronary Revascularization on the Basis of Resting Full-Cycle Ratio and Fractional Flow Reserve Measurements

The midterm prognosis of patients with deferred revascularization based on resting full cycle ratio (RFR) or fractional flow reserve (FFR) is not well established. We investigated the midterm clinical outcomes of 137 consecutive patients with deferred revascularization of 177 coronary arteries based on RFR and FFR. Patients were classified into 3 groups (concordant normal, concordant abnormal, discordant FFR and RFR), using known cutoffs for FFR (<0.80) and RFR (<0.89). All -cause mortality occurred in 9 (6.6%) and major adverse cardiac events (MACEs) in 16 patients (11.7%). Concordant abnormal, age, body mass index (BMI), and current or history of cancer were associated with increased risks of all -cause mortality. In a multivariable model, current or history of cancer was significantly associated with all -cause death (hazard ratio [HR] 6.8, p = 0.02). Concordant abnormal, current or history of cancer, BMI, and left ventricular ejection fraction were associated with increased risk of MACE, and all predictors correlated significantly with MACE (abnormal concordance: HR 4.2, p = 0.043; current or history of cancer: HR 4.0, p = 0.047; BMI: HR 0.8, p = 0.020; left ventricular ejection fraction: HR 0.9, p = 0.017). Although these results support performing percutaneous coronary intervention according to evidence -based RFR or FFR thresholds, deferred lesions with discordant FFR and RFR results were not associated with worse prognosis. 2023 Elsevier Inc. All rights reserved. (Am J Cardiol 2023;201:50-57)

Automated summary

This study investigated the midterm clinical outcomes of 137 patients with deferred revascularization based on resting full cycle ratio (RFR) and fractional flow reserve (FFR). The results showed that concordant abnormal, current or history of cancer, body mass index (BMI), and left ventricular ejection fraction were associated with increased risks of adverse outcomes.